{"id":59478,"date":"2024-06-04T10:03:35","date_gmt":"2024-06-04T08:03:35","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/"},"modified":"2024-06-04T10:03:35","modified_gmt":"2024-06-04T08:03:35","slug":"syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/","title":{"rendered":"Syngenta opens rights to genome-editing and breeding technologies to boost agricultural innovation"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\nProviding rights to academic research globally aimed at enabling solutions to<br \/>\n<br \/>complex challenges and driving sustainability in food and agriculture<\/li>\n<li>\nExpanding the potential of CRISPR-based technologies through the collaborative innovation platform<i> Shoots by Syngenta<\/i><\/li>\n<\/ul>\n<p>BASEL, Switzerland&#8211;(BUSINESS WIRE)&#8211;Syngenta Group, one of the world\u2019s largest agricultural technology companies, will provide rights to selected genome-editing and breeding technologies for academic research globally, as part of its commitment to foster innovation and drive sustainability in agriculture. These rights are accessible through its innovation collaboration platform <i>Shoots by Syngenta.<\/i><\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20240604415364\/en\/2148550\/5\/Genome_editing_Out_Licensing.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240604415364\/en\/2148550\/22\/Genome_editing_Out_Licensing.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240604415364\/en\/2148550\/5\/Genome_editing_Out_Licensing.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240604415364\/en\/2148550\/21\/Genome_editing_Out_Licensing.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240604415364\/en\/2148567\/5\/SyngentaGroup_Logo_English_RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240604415364\/en\/2148567\/22\/SyngentaGroup_Logo_English_RGB.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240604415364\/en\/2148567\/5\/SyngentaGroup_Logo_English_RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240604415364\/en\/2148567\/21\/SyngentaGroup_Logo_English_RGB.jpg\"><\/a><\/p>\n<p>\nThe rights to certain intellectual property are related to optimized CRISPR-Cas12a as well as to gene-editing enabled breeding tools. Through CRISPR gene-editing, it is possible to deliver an improved plant that does not include DNA from a different species \u2013 more quickly and efficiently than otherwise possible in nature or through conventional breeding methods.<\/p>\n<p>\n\u201cThe power of CRISPR technology has incredible potential to enable crop innovation to deliver value to farmers,\u201d says Gusui Wu, Head of Global Seeds Research at Syngenta. \u201cThe increased use of CRISPR in agriculture can transform the way we approach plant breeding, accelerating the discovery and deployment of innovations that provide growers more productive and resilient crops. We are inviting universities and academic institutions from around the world to help us drive innovation to improve the sustainability of agriculture.\u201d<\/p>\n<p>\nAs a leader in this wave of technological innovation, Syngenta scientists have been continuously innovating to improve CRISPR-Cas genome editing technologies. Syngenta\u2019s scientists have engineered CRISPR Cas12a to increase both its efficiency as well as utility, significantly optimizing it as a tool for crop improvement.<\/p>\n<p>\nSyngenta has long been open to sharing technology with public and private entities, enabling straightforward, quick, and easy access to its proprietary technologies for academic and non-profit research use. One example is Syngenta\u2019s vegetable licensing platform, which allows breeding companies and academic institutes to access and breed with Syngenta germplasm.<\/p>\n<p>\nThe <i>Shoots by Syngenta<\/i> global innovation collaboration platform was created in 2023 with a goal to create partnerships aimed at finding solutions to some of the most complex challenges in food and agriculture. It brings together the external innovation ecosystem \u2013 comprising academics, research institutes, and other entities \u2013 together with Syngenta\u2019s global network of more than 6,000 scientists, to develop solutions that mitigate climate change, enhance biodiversity, and better serve smallholder as well as large-scale farmers. The platform is built upon the values of openness and transparency.<\/p>\n<p>\n\u201cAt Syngenta, we truly believe that collaboration accelerates innovation,\u201d says Stuart Harrison, Head of Global Seeds R&amp;D Partnerships. \u201cThis new initiative has tremendous potential to not only result in exciting technology innovations, but to also drive critical crop solutions that will support farmers worldwide.\u201d<\/p>\n<p>\nAdrian Percy, Executive Director of the North Carolina Plant Sciences Initiative, states: \u201cBy accessing these innovative technologies from Syngenta, the North Carolina Plant Sciences Initiative and North Carolina State University can more broadly accelerate its capabilities in genome editing. We are excited about the application of these technologies in our research programs as they will certainly enable improvement to a variety of crops to the benefit of the grower community.\u201d<\/p>\n<p>\nA simple, streamlined process has been established for licensing the technologies. Additional information regarding the available technologies can be searched via the online catalogue on the <i>Shoots by Syngenta<\/i> website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fshootsbysyngenta.com%2Foutlicensing&amp;esheet=54026505&amp;newsitemid=20240604415364&amp;lan=en-US&amp;anchor=https%3A%2F%2Fshootsbysyngenta.com%2Foutlicensing&amp;index=1&amp;md5=a5906f101fd42b850670496192b3d748\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/shootsbysyngenta.com\/outlicensing<\/a>.<\/p>\n<p>\n<b>About Syngenta Group<\/b><\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.syngentagroup.com%2Fen&amp;esheet=54026505&amp;newsitemid=20240604415364&amp;lan=en-US&amp;anchor=Syngenta+Group&amp;index=2&amp;md5=47c522fb262cf40258ca2664e7f89bee\" rel=\"nofollow noopener\" shape=\"rect\">Syngenta Group<\/a> is one of the world\u2019s biggest agricultural technology companies, with roots going back more than 250 years. With around 60,000 employees, operating in more than 100 countries, the company strives to transform agriculture with science-driven, technological innovations to deliver high productivity and high-quality food while fighting climate change and restoring nature. Syngenta Group works with farmers and partners to deliver four <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.syngentagroup.com%2Fsustainability&amp;esheet=54026505&amp;newsitemid=20240604415364&amp;lan=en-US&amp;anchor=Sustainability+Priorities&amp;index=3&amp;md5=3d403418551dd5c0d7896b0af57e6eac\" rel=\"nofollow noopener\" shape=\"rect\">Sustainability Priorities<\/a>: Higher Yields, Lower Impact; Regenerate Soil and Nature; Improve Rural Prosperity; and Sustainable Operations. The priorities are underpinned by <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.syngentagroup.com%2Fregenerative-agriculture&amp;esheet=54026505&amp;newsitemid=20240604415364&amp;lan=en-US&amp;anchor=regenerative+agriculture&amp;index=4&amp;md5=3ba5da193bb184f2efb29bf45e8679b2\" rel=\"nofollow noopener\" shape=\"rect\">regenerative agriculture<\/a> practices to nurture and restore soil health, protect the climate and biodiversity, and enhance farm productivity and profitability. Syngenta Group, which is registered in Shanghai, China, and has its management headquarters in Switzerland, draws strength from its four business units: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.syngenta.com%2Fen&amp;esheet=54026505&amp;newsitemid=20240604415364&amp;lan=en-US&amp;anchor=Syngenta+Crop+Protection&amp;index=5&amp;md5=439026f4977c5b57c88346ee8396979e\" rel=\"nofollow noopener\" shape=\"rect\">Syngenta Crop Protection<\/a>, headquartered in Switzerland; <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.syngenta.com%2Fen%2Fseeds&amp;esheet=54026505&amp;newsitemid=20240604415364&amp;lan=en-US&amp;anchor=Syngenta+Seeds&amp;index=6&amp;md5=8f6637cb9ff82a9d8d03bf58acfb0d0c\" rel=\"nofollow noopener\" shape=\"rect\">Syngenta Seeds<\/a>, headquartered in the United States; <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.adama.com%2Fen&amp;esheet=54026505&amp;newsitemid=20240604415364&amp;lan=en-US&amp;anchor=ADAMA%26%23174%3B%2C&amp;index=7&amp;md5=5618d4f40ff69310284cd12466d58a4b\" rel=\"nofollow noopener\" shape=\"rect\">ADAMA\u00ae,<\/a> headquartered in Israel; and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.syngentagroup.cn%2F&amp;esheet=54026505&amp;newsitemid=20240604415364&amp;lan=en-US&amp;anchor=Syngenta+Group+China&amp;index=8&amp;md5=aecbe7939e98a020ebc1ce37778dbe23\" rel=\"nofollow noopener\" shape=\"rect\">Syngenta Group China<\/a>. Together, these businesses provide industry-leading ways to serve customers around the world.<\/p>\n<p>\nFor Syngenta Group photos and videos, please visit the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.syngentagroup.com%2Fen%2Fmedia%2Fmedia-library&amp;esheet=54026505&amp;newsitemid=20240604415364&amp;lan=en-US&amp;anchor=Syngenta+Group+Media+Library&amp;index=9&amp;md5=ed76570b04b228122c92b9acde3aedef\" rel=\"nofollow noopener\" shape=\"rect\">Syngenta Group Media Library<\/a>.<\/p>\n<p>\nData protection is important to us. You are receiving this publication on the legal basis of Article 6 para 1 lit. f GDPR (\u201clegitimate interest\u201d). However, if you do not wish to receive further information about Syngenta Group, just send us a brief informal message and we will no longer process your details for this purpose. You can also find further details in our <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.syngentagroup.com%2F&amp;esheet=54026505&amp;newsitemid=20240604415364&amp;lan=en-US&amp;anchor=privacy+statement&amp;index=10&amp;md5=7a7f4e097e67af05a020fcab21209b5e\" rel=\"nofollow noopener\" shape=\"rect\">privacy statement<\/a>.<\/p>\n<p>\n<b>Cautionary Statement Regarding Forward-Looking Statements<\/b><\/p>\n<p>\nThis document may contain forward-looking statements, which can be identified by terminology such as \u201cexpect,\u201d \u201cwould,\u201d \u201cwill,\u201d \u201cpotential,\u201d \u201cplans,\u201d \u201cprospects,\u201d \u201cestimated,\u201d \u201caiming,\u201d \u201con track\u201d and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. For Syngenta Group, such risks and uncertainties include risks relating to legal proceedings, regulatory approvals, new product development, increasing competition, customer credit risk, general economic and market conditions, compliance and remediation, intellectual property rights, implementation of organizational changes, impairment of intangible assets, consumer perceptions of genetically modified crops and organisms or crop protection chemicals, climatic variations, fluctuations in exchange rates and\/or grain prices, single source supply arrangements, political uncertainty, natural disasters, and breaches of data security or other disruptions of information technology. Syngenta Group assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nMedia Relations<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#105;&#x6c;&#x74;&#x6f;&#x3a;m&#101;&#100;&#105;&#x61;&#x40;&#x73;yn&#103;&#101;&#x6e;&#x74;&#x61;gr&#111;&#117;&#x70;&#x2e;&#x63;om\" rel=\"nofollow noopener\" shape=\"rect\">&#x6d;&#101;d&#x69;&#97;&#64;&#x73;&#121;n&#x67;&#101;n&#x74;&#97;g&#x72;&#111;u&#x70;&#46;c&#x6f;&#109;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Providing rights to academic research globally aimed at enabling solutions to complex challenges and driving sustainability in food and agriculture Expanding the potential of CRISPR-based technologies through the collaborative innovation platform Shoots by Syngenta BASEL, Switzerland&#8211;(BUSINESS WIRE)&#8211;Syngenta Group, one of the world\u2019s largest agricultural technology companies, will provide rights to selected genome-editing and breeding technologies &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59478","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Syngenta opens rights to genome-editing and breeding technologies to boost agricultural innovation - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Syngenta opens rights to genome-editing and breeding technologies to boost agricultural innovation - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Providing rights to academic research globally aimed at enabling solutions to complex challenges and driving sustainability in food and agriculture Expanding the potential of CRISPR-based technologies through the collaborative innovation platform Shoots by Syngenta BASEL, Switzerland&#8211;(BUSINESS WIRE)&#8211;Syngenta Group, one of the world\u2019s largest agricultural technology companies, will provide rights to selected genome-editing and breeding technologies ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-04T08:03:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240604415364\/en\/2148550\/22\/Genome_editing_Out_Licensing.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Syngenta opens rights to genome-editing and breeding technologies to boost agricultural innovation\",\"datePublished\":\"2024-06-04T08:03:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\\\/\"},\"wordCount\":963,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240604415364\\\/en\\\/2148550\\\/22\\\/Genome_editing_Out_Licensing.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\\\/\",\"name\":\"Syngenta opens rights to genome-editing and breeding technologies to boost agricultural innovation - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240604415364\\\/en\\\/2148550\\\/22\\\/Genome_editing_Out_Licensing.jpg\",\"datePublished\":\"2024-06-04T08:03:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240604415364\\\/en\\\/2148550\\\/22\\\/Genome_editing_Out_Licensing.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240604415364\\\/en\\\/2148550\\\/22\\\/Genome_editing_Out_Licensing.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Syngenta opens rights to genome-editing and breeding technologies to boost agricultural innovation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Syngenta opens rights to genome-editing and breeding technologies to boost agricultural innovation - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/","og_locale":"en_US","og_type":"article","og_title":"Syngenta opens rights to genome-editing and breeding technologies to boost agricultural innovation - Pharma Trend","og_description":"Providing rights to academic research globally aimed at enabling solutions to complex challenges and driving sustainability in food and agriculture Expanding the potential of CRISPR-based technologies through the collaborative innovation platform Shoots by Syngenta BASEL, Switzerland&#8211;(BUSINESS WIRE)&#8211;Syngenta Group, one of the world\u2019s largest agricultural technology companies, will provide rights to selected genome-editing and breeding technologies ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/","og_site_name":"Pharma Trend","article_published_time":"2024-06-04T08:03:35+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240604415364\/en\/2148550\/22\/Genome_editing_Out_Licensing.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Syngenta opens rights to genome-editing and breeding technologies to boost agricultural innovation","datePublished":"2024-06-04T08:03:35+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/"},"wordCount":963,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240604415364\/en\/2148550\/22\/Genome_editing_Out_Licensing.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/","url":"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/","name":"Syngenta opens rights to genome-editing and breeding technologies to boost agricultural innovation - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240604415364\/en\/2148550\/22\/Genome_editing_Out_Licensing.jpg","datePublished":"2024-06-04T08:03:35+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240604415364\/en\/2148550\/22\/Genome_editing_Out_Licensing.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240604415364\/en\/2148550\/22\/Genome_editing_Out_Licensing.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/syngenta-opens-rights-to-genome-editing-and-breeding-technologies-to-boost-agricultural-innovation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Syngenta opens rights to genome-editing and breeding technologies to boost agricultural innovation"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59478","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59478"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59478\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59478"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59478"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59478"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}